AKR1B1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA026425

Antibody CAB018773

Antibody CAB027391

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant gliomas, testicular seminomas and a few renal cancers showed weak to moderate cytoplasmic and nuclear immunoreactivity. Malignant cells in general were negative.Renal cancers exhibited moderate to strong cytoplasmic staining while a majority of testicular cancers, thyroid cancers, malignant gliomas and lymphomas displayed moderate immunoreactivity. The remaining tumors generally showed weak staining or were negative.Many renal and thyroid cancers showed moderate to strong staining in cytoplasm and nucleus while a majority of ovarian cancers, urothelial cancers, malignant gliomas, lymphomas and melanomas showed weak to moderate staining. Remaining malignancies were generally negative.

Validation

Supportive: Two (or more) antibodies yielding partly similar staining patterns which are consistent with gene/protein characterization data
Supportive: Two (or more) antibodies yielding partly similar staining patterns which are consistent with gene/protein characterization data
Supportive: Two (or more) antibodies yielding partly similar staining patterns which are consistent with gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected